Gates Foundation partners with Indian manufacturer to drive down cost of groundbreaking HIV prevention tool
Sierra Leone Telegraph: 24 September 2025: Millions more people at risk of HIV in low- and middle-income countries (LMICs) will have access to a powerful new prevention option: a low-cost, generic version of lenacapavir, the world’s first twice-yearly injectable pre-exposure prophylaxis (PrEP). A new partnership announced today between the Gates [Read More]